# Iteration 5: Stabilization + Adversarial Replay

## Focus
Stabilization pass (satisfies `minStabilizationPasses >= 1` after 4/4 coverage was reached in Iteration 4) and adversarial self-check of every recorded finding: try to ESCALATE each P2 to P1/P0 or REFUTE it, and confirm no P0/P1 blocker was missed in the unbuilt-phase scope.

## Scorecard
- Dimensions covered: stabilization across all 4 (no new dimension)
- Files reviewed: re-examined evidence for F001-F004
- New findings: P0=0 P1=0 P2=0
- Refined findings: P0=0 P1=0 P2=0
- New findings ratio: 0.0

## Findings

_No new findings. Adversarial replay confirmed all four advisories (F001-F004) remain P2._

## Adversarial Replay (escalate-or-refute)
- **F001** (NO-GO count) — *Escalate to P1?* No. The spec scope (`spec.md:83`) explicitly declares the consolidated list contains "non-GO and conditional" entries, so the 18 is an internally-declared target, not a fabrication. A downstream author can reconcile it by pinning the 8 novel rows. Impact is doc precision, not a wrong/blocking deliverable. **Holds at P2.**
- **F002** (stale `eval`/`evals` path) — *Escalate to P1?* No. The harness is locatable one directory over and `plan.md:109` already cites the correct basename. No deliverable is blocked. **Holds at P2.**
- **F003** (`computeAuthoredDocQuality` forward ref) — *Escalate to P1?* No. Forward references to named sibling dependencies (`plan.md:161-162`) are legitimate in a governance layer whose entire purpose is to *order* future phases. The only ask is tense/labeling. **Holds at P2.**
- **F004** (research path vantage) — *Escalate to P1?* No. Cited line numbers are accurate and the convention (track-root-relative) is internally consistent, merely unstated. **Holds at P2.**
- **Missed P0/P1 sweep** — Re-scanned for correctness contradictions, security exposure, and false completion claims. None exist: the phase ships no code, introduces no write path, and makes no done-claim (implementation-summary states PLANNED). No blocker was missed.

## Cross-Reference Results
| Protocol | Status | Gate | Evidence | Notes |
|----------|--------|------|----------|-------|
| spec_code | partial (stable) | hard | Iteration 3 | Replay re-confirmed: partial = two P2 pointers, no completion contradiction |
| checklist_evidence | pass (stable) | hard | Iteration 3 | Replay re-confirmed: zero checked items, honest PLANNED |

## Assessment
- New findings ratio: 0.0
- Dimensions addressed: stabilization (all 4 stable)
- Novelty justification: No novelty by design — this is the stabilization/replay pass. Coverage stable at 4/4 across two passes (iter 4 → iter 5). Adversarial replay upheld all four P2 severities. Evidence, scope, and coverage gates pass. Legal STOP is satisfied.

## Convergence Decision
STOP. Gate results:
- convergenceGate: pass (rolling avg of last 2 ratios = 0.0 < 0.08)
- dimensionCoverageGate: pass (4/4, stable ≥ 1 pass)
- p0ResolutionGate: pass (0 active P0)
- evidenceDensityGate: pass (every finding carries file:line)
- hotspotSaturationGate: pass (two consecutive 0.0-ratio passes)
- claimAdjudicationGate: pass (no new P0/P1 → no packet required)
- fixCompletenessReplayGate: pass (no fix under review; observation-only)
- candidateCoverageGate: pass (review-depth-v2 inactive; trivial pass)
- graphlessFallbackGate: pass (v2 inactive; trivial pass)

## Ruled Out
- "Run to maxIterations (6) for more coverage": Ruled out. The finding surface is saturated for an unbuilt phase; a 6th iteration would re-walk the same scaffold with no new dimension to cover. STOP at convergence is correct.

## Dead Ends
- None new.

## Recommended Next Focus
Synthesis: compile `review-report.md` with verdict PASS (hasAdvisories=true, 4 active P2), Planning Trigger → changelog (PASS routes to `/create:changelog`), and a Deferred Items section listing the four P2 advisories for the build phase to absorb.

Review verdict: PASS
